Effective mosaic-based nanovaccines against avian influenza in poultry.
暂无分享,去创建一个
B. Narasimhan | Y. Kawaoka | M. Hatta | M. Suresh | K. Ross | A. Talaat | S. Chandrasekar | J. Osorio | Y. Phanse | Brock Kingstad-Bakke
[1] S. Bourgault,et al. Nanoparticle-Based Vaccines Against Respiratory Viruses , 2019, Front. Immunol..
[2] Lei Deng,et al. Universal influenza vaccines: from viruses to nanoparticles , 2018, Expert review of vaccines.
[3] B. Narasimhan,et al. Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry , 2018, International journal of nanomedicine.
[4] D. Kapczynski,et al. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens. , 2018, Vaccine.
[5] B. Narasimhan,et al. Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections , 2018, Front. Immunol..
[6] Florian Krammer,et al. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies , 2018, Nature Communications.
[7] Christopher D Spicer,et al. Peer-reviewed version of the manuscript published in final form at Chemical Society Reviews (2018) Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications , 2018 .
[8] B. Narasimhan,et al. Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity , 2018, Front. Immunol..
[9] B. Narasimhan,et al. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf , 2018, Scientific Reports.
[10] K. Broman,et al. A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques , 2017, PloS one.
[11] K. Kang,et al. Polyanhydride nanovaccine against swine influenza virus in pigs. , 2017, Vaccine.
[12] J. Gelb,et al. Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age , 2016, Avian Diseases.
[13] J. Osorio,et al. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses , 2016, Journal of Virology.
[14] M. Shi,et al. Diversity and evolution of avian influenza viruses in live poultry markets, free-range poultry and wild wetland birds in China. , 2016, The Journal of general virology.
[15] P. Hosseini,et al. Genetically Diverse Low Pathogenicity Avian Influenza A Virus Subtypes Co-Circulate among Poultry in Bangladesh , 2016, PloS one.
[16] R. Booy,et al. Mismatching between circulating strains and vaccine strains of influenza: Effect on Hajj pilgrims from both hemispheres , 2016, Human vaccines & immunotherapeutics.
[17] Justin R. Adams,et al. Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza. , 2016, ACS biomaterials science & engineering.
[18] D. Suarez,et al. Poultry vaccination directed evolution of H9N2 low pathogenicity avian influenza viruses in Korea. , 2016, Virology.
[19] A. Read,et al. Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens , 2015, PLoS biology.
[20] D. Kapczynski,et al. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. , 2015, Vaccine.
[21] M. Jhung,et al. Outbreaks of Avian Influenza A (H5N2), (H5N8), and (H5N1) Among Birds — United States, December 2014–January 2015 , 2015, MMWR. Morbidity and mortality weekly report.
[22] S. Carpenter,et al. Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity , 2014, International journal of nanomedicine.
[23] D. Swayne,et al. Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies , 2014, Veterinary Research.
[24] Tavis K. Anderson,et al. Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene , 2014, Journal of Virology.
[25] D. Stallknecht,et al. Subtype diversity and reassortment potential for co-circulating avian influenza viruses at a diversity hot spot. , 2014, The Journal of animal ecology.
[26] E. Holmes,et al. Emergence of a Highly Pathogenic Avian Influenza Virus from a Low-Pathogenic Progenitor , 2014, Journal of Virology.
[27] M. Killian. Hemagglutination assay for influenza virus. , 2014, Methods in molecular biology.
[28] B. Narasimhan,et al. Safety and Biocompatibility of Carbohydrate-Functionalized Polyanhydride Nanoparticles , 2014, The AAPS Journal.
[29] R. Webster,et al. Natural history of highly pathogenic avian influenza H5N1. , 2013, Virus research.
[30] B. Narasimhan,et al. Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles. , 2013, Acta biomaterialia.
[31] C. Davis,et al. A High Diversity of Eurasian Lineage Low Pathogenicity Avian Influenza A Viruses Circulate among Wild Birds Sampled in Egypt , 2013, PloS one.
[32] B. Narasimhan,et al. Evaluation of Biocompatibility and Administration Site Reactogenicity of Polyanhydride‐Particle‐Based Platform for Vaccine Delivery , 2013, Advanced healthcare materials.
[33] B. Narasimhan,et al. Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. , 2013, Journal of biomedical materials research. Part B, Applied biomaterials.
[34] S. Plotkin,et al. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. , 2012, Vaccine.
[35] Low-pathogenic avian influenza virus A/turkey/Ontario/6213/1966 (H5N1) is the progenitor of highly pathogenic A/turkey/Ontario/7732/1966 (H5N9). , 2012, The Journal of general virology.
[36] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[37] Theo M Bestebroer,et al. Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.
[38] P. Wilson,et al. Targeting B cell responses in universal influenza vaccine design. , 2011, Trends in immunology.
[39] A. García-Sastre,et al. Influenza A viruses: new research developments , 2011, Nature Reviews Microbiology.
[40] B. Narasimhan,et al. Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases , 2011, PloS one.
[41] S. Mittal,et al. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses , 2010, Human vaccines.
[42] B. Narasimhan,et al. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.
[43] P. Wright. Vaccine preparedness--are we ready for the next influenza pandemic? , 2008, The New England journal of medicine.
[44] H. Ehrlich,et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. , 2008, The New England journal of medicine.
[45] T. Mettenleiter,et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. , 2008, Vaccine.
[46] J. Lowenthal,et al. ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken. , 2008, Developmental and comparative immunology.
[47] Balaji Narasimhan,et al. Amphiphilic polyanhydrides for protein stabilization and release. , 2007, Biomaterials.
[48] M. Feinberg,et al. Differences and Similarities in Viral Life Cycle Progression and Host Cell Physiology after Infection of Human Dendritic Cells with Modified Vaccinia Virus Ankara and Vaccinia Virus , 2006, Journal of Virology.
[49] Balaji Narasimhan,et al. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. , 2006, Journal of biomedical materials research. Part A.
[50] Wentao Gao,et al. Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization , 2006, Journal of Virology.
[51] I. Brown,et al. Recombination Resulting in Virulence Shift in Avian Influenza Outbreak, Chile , 2004, Emerging infectious diseases.
[52] R. Cox,et al. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.
[53] I. Capua,et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy , 2001, Archives of Virology.
[54] Tokiko Watanabe,et al. Generation of influenza A viruses entirely from cloned cDNAs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[55] Maricarmen García,et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. , 1999, Vaccine.
[56] R. Webster,et al. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. , 1995, Virology.
[57] H. Stone. Efficacy of avian influenza oil-emulsion vaccines in chickens of various ages. , 1987, Avian diseases.
[58] W. J. Bean,et al. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature , 1985, Journal of virology.
[59] P. Wright,et al. Behavior of Vaccine Revertants of Temperature-Sensitive Mutants of Influenza Virus in Ferret Tracheal Organ Culture , 1979, Infection and immunity.